Cell surface regulators of complement, 512 antigen, and CD59, in the rat eye and adnexal tissues

被引:0
|
作者
Bardenstein, DS
Cheyer, C
Okada, N
Morgan, BP
Medof, ME
机构
[1] Case Western Reserve Univ, Sch Med, Inst Pathol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Ctr Vis Res, Cleveland, OH 44106 USA
[3] Nagoya City Univ, Sch Med, Dept Mol Biol, Nagoya, Aichi 467, Japan
[4] Cardiff Univ, Dept Med Biochem, Cardiff CF4 4XN, S Glam, Wales
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Cell surface complement regulatory proteins have been identified in high levels in ocular tissues, but no experimental model is available for examining their physiological roles. To develop such a model, the distribution of 512 antigen, a protein possessing the functions of the human decay-accelerating factor (DAF [CD55]) and membrane cofactor protein (MCP [CD46]), and rat inhibitory protein (CD59), the homologue of the human membrane inhibitor of reactive lysis (MIRL[CD59]) were characterized in the rat eye and ocular adnexal structures. METHODS. After euthanasia of female Wistar rats, followed by orbital exenteration, eyelids and orbital tissue including the lacrimal gland were separated from the globes and immediately snap-frozen in liquid nitrogen at -70 degrees C. Tissues then were sectioned at -20 degrees C and examined immunohistochemically for 512 antigen and rat CD59. RESULTS. Both molecules were found to be present in high levels in multiple sites. Corneal and conjunctival epithelia showed moderate to intense labeling for both regulators. Fibroblasts in the corneal stroma, conjunctiva, and sclera labeled similarly. Corneal endothelial cells showed intense labeling for rat CD59 but not for 512 antigen. The iris and ciliary body showed intense labeling for both proteins. The retina showed labeling at multiple levels, with that of rat CD59 being more intense than that of 512 antigen. The lacrimal gland labeled for both regulators. Vessels, muscle, and nerves in the orbit labeled intensely for both antigens. In the eyelid, conjunctiva, sebaceous glands, and muscle and nerve tissues labeled moderately to intensely for both molecules, whereas skin epithelium labeled less intensely. CONCLUSIONS. 512 antigen and rat CD59 are expressed in high levels and distributed similarly in the rat eye and lacrimal gland to DAF, MCP, and MIRL in the human eye and lacrimal gland. These findings establish the rat ocular surface as a model for studying the role of cell surface complement regulators in this site. This first identification of copious expression of these proteins in eyelid structures. which also participate in protection of the ocular surface, further suggests an important role for surface complement regulatory proteins in this location.
引用
收藏
页码:519 / 524
页数:6
相关论文
共 50 条
  • [21] IDENTITY OF A PEPTIDE DOMAIN OF HUMAN C9 THAT IS BOUND BY THE CELL-SURFACE COMPLEMENT INHIBITOR, CD59
    CHANG, CP
    HUSLER, T
    ZHAO, J
    WIEDMER, T
    SIMS, PJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (42) : 26424 - 26430
  • [22] Expression of membrane complement regulators, CD46, CD55 and CD59, in mesothelial cells of patients on peritoneal dialysis therapy
    Sei, Yumi
    Mizuno, Masashi
    Suzuki, Yasuhiro
    Imai, Masaki
    Higashide, Keiko
    Harris, Claire L.
    Sakata, Fumiko
    Iguchi, Daiki
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    Maruyama, Shoichi
    Matsuo, Seiichi
    Ito, Yasuhiko
    MOLECULAR IMMUNOLOGY, 2015, 65 (02) : 302 - 309
  • [23] Membrane-bound regulators of complement activation in uveal melanomas - CD46, CD55, and CD59 in uveal melanomas
    Goslings, WRO
    Blom, DJR
    deWaardSiebinga, I
    vanBeelen, E
    Claas, FHJ
    Jager, MJ
    Gorter, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (09) : 1884 - 1891
  • [24] EXPRESSION AND REGULATION OF THE MEMBRANE-ASSOCIATED COMPLEMENT-REGULATORS CD46, CD55 AND CD59 IN GASTROINTESTINAL CELLS
    SCHMITT, C
    SCHWAEBLE, W
    WITTIG, B
    ZUMBUSCHENFELDE, KHM
    DIPPOLD, W
    GASTROENTEROLOGY, 1994, 106 (04) : A768 - A768
  • [25] CD59 expression and complement susceptibility of human neuronal cell line (NTera2)
    Agoropoulou, C
    Wing, MG
    Wood, A
    NEUROREPORT, 1996, 7 (05) : 997 - 1004
  • [26] Cell surface complement inhibitors CD55 and CD59 may mediate chronic lymphocytic leukemia (CLL) resistance to rituximab therapy
    Bannerji, R
    Pearson, M
    Flinn, IW
    Shinn, CA
    Goodrich, A
    Lucas, M
    Byrd, JC
    BLOOD, 2000, 96 (11) : 164A - 164A
  • [27] Role of CD59 in T cell activation induced by non-lethal complement attack
    韩根成
    白云
    姜曼
    黎万玲
    朱锡华
    Journal of Medical Colleges of PLA , 2001, (01) : 19 - 23
  • [28] REGULATION OF COMPLEMENT ACTIVATION IN RAT-LIVER ISCHEMIA AND REPERFUSION - EXPRESSION OF ENDOTHELIAL CD59 (RIP)
    CHAVEZCARTAYA, R
    COZZI, E
    PINODESOLA, G
    JAMIESON, NV
    WHITE, DJG
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (05) : 2852 - 2854
  • [29] Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections
    Nuutila, Jari
    Jalava-Karvinen, Paivi
    Hohenthal, Ulla
    Kotilainen, Pirkko
    Pelliniemi, Tarja-Terttu
    Nikoskelainen, Jukka
    Lilius, Esa-Matti
    HUMAN IMMUNOLOGY, 2013, 74 (05) : 522 - 530
  • [30] CONTRIBUTION OF THE N-LINKED CARBOHYDRATE OF ERYTHROCYTE ANTIGEN CD59 TO ITS COMPLEMENT-INHIBITORY ACTIVITY
    NINOMIYA, H
    STEWART, BH
    ROLLINS, SA
    ZHAO, J
    BOTHWELL, ALM
    SIMS, PJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (12) : 8404 - 8410